VSR Financial Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-7,828
Closed -$508K 561
2016
Q1
$508K Buy
7,828
+4,536
+138% +$309K 0.05% 325
2015
Q4
$254K Buy
3,292
+83
+3% +$6.59K 0.03% 467
2015
Q3
$264K Sell
3,209
-824
-20% -$73.3K 0.03% 443
2015
Q2
$355K Buy
4,033
+62
+2% +$5.69K 0.04% 409
2015
Q1
$351K Sell
3,971
-111
-3% -$9.85K 0.04% 411
2014
Q4
$339K Sell
4,082
-1,685
-29% -$140K 0.04% 399
2014
Q3
$486K Buy
5,767
+416
+8% +$33.7K 0.06% 334
2014
Q2
$434K Buy
5,351
+2,139
+67% +$168K 0.05% 353
2014
Q1
$245K Sell
3,212
-571
-15% -$41.6K 0.03% 487
2013
Q4
$272K Buy
3,783
+80
+2% +$5.56K 0.04% 445
2013
Q3
$254K Buy
3,703
+166
+5% +$11K 0.04% 425
2013
Q2
$224K Buy
+3,537
New +$230K 0.04% 443

Other funds holding NVS

VSR Financial Services's NVS Position: Q2 2016 in Review

VSR Financial Services sold out of Novartis (NVS) in Q2 2016, closing a stake of 7,828 shares — an estimated $508K sold.

VSR Financial Services first reported a position in NVS in Q2 2013 and held it in 12 quarters. The position peaked at $508K in Q1 2016. 878 funds tracked by Wall St. Rank hold NVS as of Q2 2016.

  • VSR Financial Services reported no remaining Novartis position as of Q2 2016 after selling out during the quarter.
  • VSR Financial Services sold 7,828 Novartis shares in Q2 2016, an estimated $508K.
  • VSR Financial Services first reported a position in Novartis in Q2 2013 and held it in 12 quarters.
  • VSR Financial Services's Novartis position peaked at $508K in Q1 2016.
  • 878 funds tracked by Wall St. Rank held Novartis as of Q2 2016.

Based on VSR Financial Services's 13F filing for Q2 2016, filed 11 Aug 2016.